Advancing the frontiers of virology in Africa: The African Virologists Network's Mission and Progress

IF 2.8 3区医学 Q3 VIROLOGY

Virology Pub Date : 2025-02-27 DOI:10.1016/j.virol.2025.110469

Onoja Anyebe Bernard , Sabastine Eugene Arthur , Maryam Aminu , Evelyn Yayra Bonney , Abdul-Azeez A. Anjorin , Gilbert Nchongboh Chofong , Anna Kafintu-kwashie , Claude Taurai Sabeta , Abdelaziz A. Yassin , Theophilus Korku Adiku

{"title":"Advancing the frontiers of virology in Africa: The African Virologists Network's Mission and Progress","authors":"Onoja Anyebe Bernard , Sabastine Eugene Arthur , Maryam Aminu , Evelyn Yayra Bonney , Abdul-Azeez A. Anjorin , Gilbert Nchongboh Chofong , Anna Kafintu-kwashie , Claude Taurai Sabeta , Abdelaziz A. Yassin , Theophilus Korku Adiku","doi":"10.1016/j.virol.2025.110469","DOIUrl":null,"url":null,"abstract":"<div><div>Africa has long been a hotspot for emerging and re-emerging viral infections such as Ebola, Mpox, Lassa fever, HIV, and arboviruses. Despite the continent's critical role in virology, African virologists have historically lacked a dedicated platform for collaboration and influence in global health policies. The African Virologists Network (AVN) was established in 2019 to address these gaps, fostering research collaboration, knowledge exchange, and capacity building. This article details the history of AVN, its initiatives, and its impact, including the African Virology Congress (AVC), the AVN webinar series, and its advocacy for enhanced virological research and policy engagement in Africa. The AVN's achievements underscore its role in strengthening Africa's response to viral diseases and ensuring African scientists play a leading role in global virology.</div></div>","PeriodicalId":23666,"journal":{"name":"Virology","volume":"606 ","pages":"Article 110469"},"PeriodicalIF":2.8000,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Virology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0042682225000819","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"VIROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Africa has long been a hotspot for emerging and re-emerging viral infections such as Ebola, Mpox, Lassa fever, HIV, and arboviruses. Despite the continent's critical role in virology, African virologists have historically lacked a dedicated platform for collaboration and influence in global health policies. The African Virologists Network (AVN) was established in 2019 to address these gaps, fostering research collaboration, knowledge exchange, and capacity building. This article details the history of AVN, its initiatives, and its impact, including the African Virology Congress (AVC), the AVN webinar series, and its advocacy for enhanced virological research and policy engagement in Africa. The AVN's achievements underscore its role in strengthening Africa's response to viral diseases and ensuring African scientists play a leading role in global virology.

查看原文本刊更多论文

推进非洲病毒学前沿：非洲病毒学家网络的使命和进展。

非洲长期以来一直是埃博拉、麻疹、拉沙热、艾滋病毒和虫媒病毒等新发和再发病毒感染的热点地区。尽管非洲大陆在病毒学方面发挥着关键作用，但非洲病毒学家历来缺乏一个专门的合作平台，无法对全球卫生政策产生影响。非洲病毒学家网络（AVN）成立于2019年，旨在解决这些差距，促进研究合作、知识交流和能力建设。本文详细介绍了非洲病毒学大会的历史、倡议及其影响，包括非洲病毒学大会（AVC）、AVN网络系列研讨会，以及它对加强非洲病毒学研究和政策参与的倡导。非洲病毒网络的成就强调了它在加强非洲对病毒性疾病的反应和确保非洲科学家在全球病毒学中发挥领导作用方面的作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Virology 医学-病毒学

CiteScore

6.00

自引率

0.00%

发文量

157

审稿时长

50 days

期刊介绍： Launched in 1955, Virology is a broad and inclusive journal that welcomes submissions on all aspects of virology including plant, animal, microbial and human viruses. The journal publishes basic research as well as pre-clinical and clinical studies of vaccines, anti-viral drugs and their development, anti-viral therapies, and computational studies of virus infections. Any submission that is of broad interest to the community of virologists/vaccinologists and reporting scientifically accurate and valuable research will be considered for publication, including negative findings and multidisciplinary work.Virology is open to reviews, research manuscripts, short communication, registered reports as well as follow-up manuscripts.